Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results

Last Modified: 12/1/2001 First Published: 12/1/1999


1.		Phase II Study of Acridine Carboxamide in Patients with Unresectable, Locally Advanced, Progressive or Metastatic Non-Small Cell Lung Cancer (Summary Last Modified 12/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								EORTC-16991N NCT00004151

Last Modified: 7/1/2000 First Published: 3/1/2000


2.		Phase II Study of Acridine Carboxamide in Patients With Recurrent Glioblastoma Multiforme (Summary Last Modified 07/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								EORTC-16991G XENOVA-XR5000/014/98, NCT00004937

Last Modified: 2/26/2008 First Published: 4/1/2001


3.		Phase II Study of Acridine Carboxamide in Patients With Advanced Ovarian Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								EORTC-16991O XENOVA-XR5000/015/98

Last Modified: 4/1/2001 First Published: 4/1/2001


4.		Phase II Study of Acridine Carboxamide in Patients With Advanced Colorectal Cancer (Summary Last Modified 04/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								EORTC-16991C XENOVA-XR5000/011/98

Select All on One Page